ATE21691T1 - Verfahren und zwischenverbindungen zur herstellung von pirbuterol und analogen verbindungen. - Google Patents

Verfahren und zwischenverbindungen zur herstellung von pirbuterol und analogen verbindungen.

Info

Publication number
ATE21691T1
ATE21691T1 AT82300602T AT82300602T ATE21691T1 AT E21691 T1 ATE21691 T1 AT E21691T1 AT 82300602 T AT82300602 T AT 82300602T AT 82300602 T AT82300602 T AT 82300602T AT E21691 T1 ATE21691 T1 AT E21691T1
Authority
AT
Austria
Prior art keywords
pirbuterol
analogues
processes
production
intermediate compounds
Prior art date
Application number
AT82300602T
Other languages
English (en)
Inventor
Berkeley Wendell Cue Jr
Stephen Sargent Massett
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE21691T1 publication Critical patent/ATE21691T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
AT82300602T 1981-02-09 1982-02-08 Verfahren und zwischenverbindungen zur herstellung von pirbuterol und analogen verbindungen. ATE21691T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23292381A 1981-02-09 1981-02-09
EP82300602A EP0058069B1 (de) 1981-02-09 1982-02-08 Verfahren und Zwischenverbindungen zur Herstellung von Pirbuterol und analogen Verbindungen

Publications (1)

Publication Number Publication Date
ATE21691T1 true ATE21691T1 (de) 1986-09-15

Family

ID=22875140

Family Applications (2)

Application Number Title Priority Date Filing Date
AT82300604T ATE20882T1 (de) 1981-02-09 1982-02-08 Verfahren und zwischenverbindungen zur herstellung von pirbuterol.
AT82300602T ATE21691T1 (de) 1981-02-09 1982-02-08 Verfahren und zwischenverbindungen zur herstellung von pirbuterol und analogen verbindungen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT82300604T ATE20882T1 (de) 1981-02-09 1982-02-08 Verfahren und zwischenverbindungen zur herstellung von pirbuterol.

Country Status (26)

Country Link
EP (4) EP0058071B1 (de)
JP (4) JPS57150665A (de)
KR (1) KR860000623B1 (de)
AR (4) AR231439A1 (de)
AT (2) ATE20882T1 (de)
AU (1) AU530826B2 (de)
CA (1) CA1179677A (de)
CS (1) CS229678B2 (de)
DD (2) DD202544A5 (de)
DE (2) DE3272793D1 (de)
DK (1) DK157541C (de)
EG (1) EG16242A (de)
ES (4) ES8305721A1 (de)
FI (1) FI820396L (de)
GR (1) GR75867B (de)
GT (1) GT198273686A (de)
IE (2) IE52326B1 (de)
IL (1) IL64954A (de)
NO (4) NO820371L (de)
NZ (1) NZ199646A (de)
PH (4) PH20622A (de)
PL (4) PL130678B1 (de)
PT (1) PT74397B (de)
SU (4) SU1194273A3 (de)
YU (3) YU42756B (de)
ZA (1) ZA82778B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615293A1 (de) * 1986-05-06 1987-11-12 Bayer Ag Verwendung von heteroarylethylaminen zur leistungsfoerderung bei tieren, heteroarylethylamine und verfahren zu ihrer herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
BE795937A (fr) * 1972-03-01 1973-08-27 Pepro Procede d'hydroxymethylation d'une 3-hydroxy-pyridine substituee
AR207639A1 (es) * 1973-12-26 1976-10-22 Pfizer Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica
US4031108A (en) * 1974-10-09 1977-06-21 Pfizer Inc. 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
NO824275L (no) 1982-08-10
IE820273L (en) 1982-08-09
JPS57150665A (en) 1982-09-17
KR830009028A (ko) 1983-12-17
IE52326B1 (en) 1987-09-16
NO824273L (no) 1982-08-10
AU8027182A (en) 1982-08-19
EP0058069A2 (de) 1982-08-18
JPS6193164A (ja) 1986-05-12
DE3272061D1 (en) 1986-08-28
GR75867B (de) 1984-08-02
YU42908B (en) 1988-12-31
YU43389B (en) 1989-06-30
JPS60208962A (ja) 1985-10-21
EP0058072A3 (de) 1982-08-25
SU1217253A3 (ru) 1986-03-07
PL235000A1 (en) 1983-04-11
EP0058070A3 (de) 1982-08-25
PH19167A (en) 1986-01-16
PT74397B (en) 1984-10-09
YU201984A (en) 1985-04-30
SU1250170A3 (ru) 1986-08-07
EP0058071A3 (en) 1982-08-25
CS229678B2 (en) 1984-06-18
NO824274L (no) 1982-08-10
AR229712A1 (es) 1983-10-31
JPS6135184B2 (de) 1986-08-12
PL239427A1 (en) 1983-04-25
AR229373A1 (es) 1983-07-29
ES518971A0 (es) 1984-03-01
GT198273686A (es) 1983-07-30
IL64954A (en) 1986-03-31
ES8403111A1 (es) 1984-03-01
PL130678B1 (en) 1984-08-31
IE820275L (en) 1982-08-09
DE3272793D1 (en) 1986-10-02
FI820396L (fi) 1982-08-10
DK157541B (da) 1990-01-22
ES8403110A1 (es) 1984-03-01
YU42756B (en) 1988-12-31
NO820371L (no) 1982-08-10
JPS60208964A (ja) 1985-10-21
YU201884A (en) 1985-04-30
ATE20882T1 (de) 1986-08-15
ES509430A0 (es) 1983-04-16
EP0058069A3 (en) 1982-09-01
EP0058070A2 (de) 1982-08-18
DK157541C (da) 1990-06-11
AU530826B2 (en) 1983-07-28
EP0058072A2 (de) 1982-08-18
CA1179677A (en) 1984-12-18
EP0058069B1 (de) 1986-08-27
ES8403112A1 (es) 1984-03-01
JPS6059911B2 (ja) 1985-12-27
SU1194273A3 (ru) 1985-11-23
ES518972A0 (es) 1984-03-01
ZA82778B (en) 1983-01-26
KR860000623B1 (ko) 1986-05-24
PL130918B1 (en) 1984-09-29
PH19164A (en) 1986-01-16
DD210034A5 (de) 1984-05-30
PT74397A (en) 1982-03-01
ES518973A0 (es) 1984-03-01
AR231439A1 (es) 1984-11-30
PL130580B1 (en) 1984-08-31
PH20292A (en) 1986-11-18
SU1240354A3 (ru) 1986-06-23
EP0058071B1 (de) 1986-07-23
YU26682A (en) 1985-04-30
PH20622A (en) 1987-03-06
EP0058071A2 (de) 1982-08-18
IL64954A0 (en) 1982-04-30
PL239428A1 (en) 1983-04-25
PL239426A1 (en) 1983-04-25
JPS6119624B2 (de) 1986-05-17
AR229374A1 (es) 1983-07-29
PL130917B1 (en) 1984-09-29
DD202544A5 (de) 1983-09-21
ES8305721A1 (es) 1983-04-16
DK52182A (da) 1982-09-17
EG16242A (en) 1989-01-30
JPS6059231B2 (ja) 1985-12-24
IE52325B1 (en) 1987-09-16
NZ199646A (en) 1985-11-08

Similar Documents

Publication Publication Date Title
DE3689259D1 (de) Verfahren zur Herstellung von Polyolefinen.
DE3788939D1 (de) Verfahren zur Herstellung von Uretdionringen enthaltenden Polyurethanen.
ATE10609T1 (de) Verfahren zur herstellung von zementklinker.
DE3750318D1 (de) Verfahren zur Herstellung von Halosilanen.
DE3789680D1 (de) Verfahren zur Herstellung von Halbleiterbauelementen.
ATE10610T1 (de) Verfahren zur herstellung von zementklinker.
ATE51875T1 (de) Chemisches verfahren zur herstellung von antibiotikum l 17043.
ATE21508T1 (de) Verfahren zur herstellung von alphahaloalkylamiden.
ATE94538T1 (de) Verfahren zur herstellung von harnstoffen.
ATE33243T1 (de) Verfahren zur herstellung von feuerfestelementen.
ATE21691T1 (de) Verfahren und zwischenverbindungen zur herstellung von pirbuterol und analogen verbindungen.
ATE56936T1 (de) Verfahren zur herstellung von carbonylverbindungen.
ATE9167T1 (de) Verfahren und anlage zur herstellung von isomerose.
ATE49222T1 (de) Verfahren zur herstellung von elastischen formkoerpern.
ATE39883T1 (de) Verfahren zur herstellung von formstuecken.
DE68908681D1 (de) Verfahren zur Herstellung von feinpulvrigem beta-Sialon.
ATE30312T1 (de) Verfahren zur herstellung von polyfluoralkylsubstituierten verbindungen.
ATE42543T1 (de) Verfahren zur herstellung von azetidinonverbindungen.
ATE19237T1 (de) Verfahren zur herstellung von acylcyaniden.
ATE30912T1 (de) Verfahren zur herstellung von nglycidylverbindungen.
ATE19396T1 (de) Verfahren zur herstellung von isochinolindionen.
ATE18898T1 (de) Verfahren zur herstellung von benzochinonen.
ATE32703T1 (de) Verfahren zur herstellung von cycloalkadienen.
ATE60086T1 (de) Verfahren zur herstellung von glukosyltransferase.
ATE27702T1 (de) Verfahren zur herstellung von beta-lactamverbindungen.